Promega Corp. v. Life Technologies Corp.
Court of Appeals for the Federal Circuit
1Opinion of the Court
CHEN, Circuit Judge.
Life Technologies, Applied Biosystems, LLC, and Invitrogen IP Holdings, Inc. (collectively, LifeTech) appeal from the district court’s grant of a motion for summary judgment that the asserted claims of United States Patent Nos. 5,843,660 ('660 patent), 6,221,598 ('598 patent), 6,479,235 ('235 patent), and 7,008,771 ('771 patent) (collectively, the Promega patents) are not invalid for lack of enablement and obviousness. Promega Corp. and Max-PlanckGesellschaft zur Forderung der Wissenschaften E.V. (collectively, Promega) appeal from a grant of a motion for judgment as a…
Also in this document: Dissent.
2Cases cited26 opinions
- Federal Deposit Insurance v. MeyerSupreme Court of the United States · 1994
- Sony Corp. of America v. Universal City Studios, Inc.Supreme Court of the United States · 1984
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Global-Tech Appliances, Inc. v. SEB S. A.Supreme Court of the United States · 2011
- Metro-Goldwyn-Mayer Studios Inc. v. Grokster, Ltd.Supreme Court of the United States · 2005
21 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- Life Technologies Corp. v. Promega Corp.Supreme Court of the United States · 2017
- Promega Corp. v. Life Technologies Corp.Court of Appeals for the Federal Circuit · 2017
- Ameritox, Ltd. v. Millennium Health, LLCDistrict Court, W.D. Wisconsin · 2015
- Barry v. Medtronic, Inc.District Court, E.D. Texas · 2017
- Canvs Corporation v. United StatesUnited States Court of Federal Claims · 2016
8 more not listed; retrieve them via the Exa API.